Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schott

Showing results (271-280 of 949) with videos related to

Pageof 95
Sort By:
JMIR Aging|December 1, 2025
End User and Primary Care Physicians' Perspectives on Digital Innovations in Dementia Risk Detection: Focus on a Digital Sleep BiomarkerRíona Mc Ardle, Marie Poole, Sophie Horrocks, et al.
Nature Reviews. Neuroscience|January 8, 2024
Data-driven modelling of neurodegenerative disease progression: thinking outside the black boxAlexandra L Young, Neil P Oxtoby, Sara Garbarino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's diseaseBryan Ng, Eleftheria Kodosaki, Elena Veleva, et al.
Journal of Microbiology & Experimentation|December 17, 2024
Randomized clinical trial to test the safety and tolerability of SBD111, an optimized synbiotic medical food combination designed for the dietary management of the metabolic processes underlying osteopenia and osteoporosisShivani Sahni, Eric M Schott, Danette Carroll, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 15, 1999
Separate and combined value of bone mass and gait speed measurements in screening for hip fracture risk: results from the EPIDOS study. Epidémiologie de l'OstéoporoseP Dargent-Molina, A M Schott, D Hans, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 14, 2012
HLA-A2 phenotype may be protective against Graves' disease but not against Hashimoto's thyroiditis in CaucasiansC Bernecker, M Ostapczuk, S Vordenbäumen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 20, 2011
FRAX® probabilities and risk of major osteoporotic fracture in FranceC M Couris, R D Chapurlat, J A Kanis, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 27, 2010
The CB-1 receptor antagonist rimonabant modulates the interaction between adipocytes and pancreatic beta-cells in vitroF Ülgen, M C Kühn, K Cupisti, et al.
Endocrine|March 16, 2013
Secondary malignancy in patients with sporadic neuroendocrine neoplasiaM Krausch, A Raffel, M Anlauf, et al.
Neuroimage|May 6, 2006
Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integralRichard G Boyes, Daniel Rueckert, Paul Aljabar, et al.
Pageof 95

Showing results (271-280 of 949) with videos related to

Sort By:
Pageof 95
JMIR Aging|December 1, 2025
End User and Primary Care Physicians' Perspectives on Digital Innovations in Dementia Risk Detection: Focus on a Digital Sleep BiomarkerRíona Mc Ardle, Marie Poole, Sophie Horrocks, et al.
Nature Reviews. Neuroscience|January 8, 2024
Data-driven modelling of neurodegenerative disease progression: thinking outside the black boxAlexandra L Young, Neil P Oxtoby, Sara Garbarino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's diseaseBryan Ng, Eleftheria Kodosaki, Elena Veleva, et al.
Journal of Microbiology & Experimentation|December 17, 2024
Randomized clinical trial to test the safety and tolerability of SBD111, an optimized synbiotic medical food combination designed for the dietary management of the metabolic processes underlying osteopenia and osteoporosisShivani Sahni, Eric M Schott, Danette Carroll, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 15, 1999
Separate and combined value of bone mass and gait speed measurements in screening for hip fracture risk: results from the EPIDOS study. Epidémiologie de l'OstéoporoseP Dargent-Molina, A M Schott, D Hans, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 14, 2012
HLA-A2 phenotype may be protective against Graves' disease but not against Hashimoto's thyroiditis in CaucasiansC Bernecker, M Ostapczuk, S Vordenbäumen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 20, 2011
FRAX® probabilities and risk of major osteoporotic fracture in FranceC M Couris, R D Chapurlat, J A Kanis, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 27, 2010
The CB-1 receptor antagonist rimonabant modulates the interaction between adipocytes and pancreatic beta-cells in vitroF Ülgen, M C Kühn, K Cupisti, et al.
Endocrine|March 16, 2013
Secondary malignancy in patients with sporadic neuroendocrine neoplasiaM Krausch, A Raffel, M Anlauf, et al.
Neuroimage|May 6, 2006
Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integralRichard G Boyes, Daniel Rueckert, Paul Aljabar, et al.
Pageof 95